Browsing by Author Quantin, Xavier

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 3 of 3
TitleAuthor(s)Issue Date
 
Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial
Journal:Lung Cancer
Naidoo, JarushkaVansteenkiste, Johan F.Faivre-Finn, CorinneÖzgüroğlu, MustafaMurakami, ShujiHui, RinaQuantin, XavierBroadhurst, HelenNewton, MichaelThiyagarajah, PirunthaAntonia, Scott J.
2022
 
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
Journal:Journal of Clinical Oncology
Spigel, David R.Faivre-Finn, CorinneGray, Jhanelle E.Vicente, DavidPlanchard, DavidPaz-Ares, LuisVansteenkiste, Johan F.Garassino, Marina C.Hui, RinaQuantin, XavierRimner, AndreasWu, Yi LongÖzgüroǧlu, MustafaLee, Ki H.Kato, TerufumiDe Wit, MaikeKurata, TakayasuReck, MartinCho, Byoung C.Senan, SureshNaidoo, JarushkaMann, HelenNewton, MichaelThiyagarajah, PirunthaAntonia, Scott J.
2022
 
Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
Journal:New England Journal of Medicine
Antonia, Scott J.Villegas, AugustoDaniel, DaveyVicente, DavidMurakami, ShujiHui, RinaKurata, TakayasuChiappori, AlbertoLee, Ki H.De Wit, MaikeCho, Byoung C.Bourhaba, MaryamQuantin, XavierTokito, TakaakiMekhail, TarekPlanchard, DavidKim, Young ChulKarapetis, Christos S.Hiret, SandrineOstoros, GyulaKubota, KaoruGray, Jhanelle E.Paz-Ares, LuisDe Castro Carpeño, JavierFaivre-Finn, CorinneReck, MartinVansteenkiste, JohanSpigel, David R.Wadsworth, CatherineMelillo, GiovanniTaboada, MariaDennis, Phillip A.Özgüroğlu, Mustafa
2018
Showing results 1 to 3 of 3